Drug

CANbridge Pharmaceuticals Doses First Patient in CAN108 Biliary Atresia Study

Sandoz Launches Pyzchiva Biosimilar of J&J's Stelara in US
CompanyDrug

Sandoz Launches Pyzchiva Biosimilar of J&J’s Stelara in US

CDE Includes Chiral Tech's Cerdelga Generic in Rare Disease Care Plan
Company

CDE Includes Chiral Tech’s Cerdelga Generic in Rare Disease Care Plan

Medtronic's BrainSense Adaptive DBS Wins FDA Approval for Parkinson's Treatment
CompanyMedical Device

Medtronic’s BrainSense Adaptive DBS Wins FDA Approval for Parkinson’s Treatment

SMPA Suspends Indobufen Procurement After Patent Infringement Verdict
Legal / IP

SMPA Suspends Indobufen Procurement After Patent Infringement Verdict

Xellsmart's iPSC Therapy XS-228 Receives FDA Approval for ALS Study
CompanyDrug

Xellsmart’s iPSC Therapy XS-228 Receives FDA Approval for ALS Study

Huadong Medicine's HDM1005 Receives NMPA Approval for OSA Treatment
CompanyDrug

Huadong Medicine’s HDM1005 Receives NMPA Approval for OSA Treatment

Pfizer's Hympavzi (Marstacimab) Launched in China's Boao Lecheng Pilot Zone for Hemophilia
CompanyDrug

Pfizer’s Hympavzi (Marstacimab) Launched in China’s Boao Lecheng Pilot Zone for Hemophilia

Summit Therapeutics and Pfizer Collaborate on Ivonescimab-ADC Combo for Solid Tumors
CompanyDeals

Summit Therapeutics and Pfizer Collaborate on Ivonescimab-ADC Combo for Solid Tumors

Dizal Pharma's 2024 Revenues Surge 295% to RMB360M, Loss Narrows by RMB251M
Company

Dizal Pharma’s 2024 Revenues Surge 295% to RMB360M, Loss Narrows by RMB251M

Bristol-Myers Squibb's Opdivo-Yervoy Combo Nears FDA Approval for MSI-H Colorectal Cancer
CompanyDrug

Bristol-Myers Squibb’s Opdivo-Yervoy Combo Nears FDA Approval for MSI-H Colorectal Cancer

CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine
CompanyDrug

CanSino Biologics Receives NMPA Approval for DTcP Hib MCV4 Combined Vaccine